

Advances in human genetics in recent years have largely been driven by next-generation sequencing (NGS); however, the discovery of disease-related gene mutations has been biased toward the exome because the large and very repetitive regions that characterize the non-coding genome remain difficult to reach by that technology. For autosomal-dominant spinocerebellar ataxias (SCAs), 28 genes have been identified, but only five SCAs originate from non-coding mutations. Over half of SCA-affected families, however, remain without a genetic diagnosis. We used genome-wide linkage analysis, NGS, and repeat analysis to identify an (ATTTC)n insertion in a polymorphic ATTTT repeat in DAB1 in chromosomal region 1p32.2 as the cause of autosomal-dominant SCA; this region has been previously linked to SCA37. The non-pathogenic and pathogenic alleles have the configurations [(ATTTT)7–400] and [(ATTTT)60–79(ATTTC)31–75(ATTTT)58–90], respectively. (ATTTC)n insertions are present on a distinct haplotype and show an inverse correlation between size and age of onset. In the DAB1-oriented strand, (ATTTC)n is located in 5′ UTR introns of cerebellar-specific transcripts arising mostly during human fetal brain development from the usage of alternative promoters, but it is maintained in the adult cerebellum. Overexpression of the transfected (ATTTC)58 insertion, but not (ATTTT)n, leads to abnormal nuclear RNA accumulation. Zebrafish embryos injected with RNA of the (AUUUC)58 insertion, but not (AUUUU)n, showed lethal developmental malformations. Together, these results establish an unstable repeat insertion in DAB1 as a cause of cerebellar degeneration; on the basis of the genetic and phenotypic evidence, we propose this mutation as the molecular basis for SCA37. © 2017 American Society of Human Genetics
| EMTREE drug terms: | genomic DNAmessenger RNAnuclear RNAspacer DNAuntranslated RNADAB1 protein, humanmessenger RNAmicrosatellite DNAnerve proteinRNAsignal transducing adaptor proteinspacer DNA |
|---|---|
| EMTREE medical terms: | adultalleleanimal experimentArticlebrain developmentchromosomal mappingchromosome 1pDAB1 geneembryofemalefetusfetus brainfluorescence in situ hybridizationgenegene expressiongene insertion sequencegene mappinggenome-wide association studygenotypehaplotypeHEK293T cell linehumanhuman celllinkage analysismalenonhumanpriority journalSCA37 genesingle nucleotide polymorphismSouthern blottingspinocerebellar degenerationzebra fishadolescentcerebellumchromosomal mappingchromosome 1chromosome segregationdna mutational analysisembryo developmentgene expression regulationgenetic predispositiongeneticsHEK293 cell lineintronmetabolismmiddle agednucleotide sequenceonset agepedigreespinocerebellar degenerationyoung adult |
| MeSH: | Adaptor Proteins, Signal TransducingAdolescentAdultAge of OnsetAllelesBase SequenceCerebellumChromosome SegregationChromosomes, Human, Pair 1DNA Mutational AnalysisDNA, IntergenicEmbryonic DevelopmentFemaleGenetic Predisposition to DiseaseHaplotypesHEK293 CellsHumansIntronsMaleMicrosatellite RepeatsMiddle AgedMutagenesis, InsertionalNerve Tissue ProteinsPedigreePhysical Chromosome MappingRNARNA, MessengerSpinocerebellar AtaxiasYoung Adult |
RNA, 63231-63-0;
Adaptor Proteins, Signal Transducing; DAB1 protein, human; DNA, Intergenic; Nerve Tissue Proteins; RNA; RNA, Messenger
| Funding sponsor | Funding number | Acronym |
|---|---|---|
| SFRH/BD/30702/2006,PEst-C/SAU/LA0002/2013 | ||
| Fundação Portugal Telecom | ||
| European Molecular Biology Organization See opportunities | ASTF494-2015,Norte-01-0145-FEDER-000008 | |
| Instituto de Salud Carlos III | PI12/00742 | |
| Fundação para a Ciência e a Tecnologia See opportunities | ||
| POCI-01-0145-FEDER-007274,PTDC/SAU-GMG/098305/2008 | ||
| POCI,2020 | ||
| European Regional Development Fund | ||
| Institute of Molecular and Cell Biology | ||
| NORTE |
We thank the families who participated in this study. We are grateful to Gon?alo Abecasis, Miguel Costa, Tito Vieira, and Andr? Torres for help with MERLIN analysis; Beatriz Sobrino, Jorge Amigo, and Pilar Cacheiro for next-generation sequencing analysis, performed at the Santiago de Compostela node of the Spanish National Genotyping Center; Nuno Santar?m and Anabela Cordeiro-da-Silva for assistance with cloning; Ant?nio Amorim, Laura Vilarinho, and Paula Jorge for samples from the Portuguese population; and Paula Magalh?es from the Institute for Molecular and Cell Biology Cell Culture and Genotyping Core for DNA extraction. This work was financed by Fundo Europeu de Desenvolvimento Regional (FEDER) funds through the COMPETE 2020 Operational Program for Competitiveness and Internationalization (POCI) of Portugal 2020 and by Portuguese funds through the Funda??o para a Ci?ncia e a Tecnologia (FCT) and Minist?rio da Ci?ncia, Tecnologia, e Inova??o in the framework of the project ?Institute for Research and Innovation in Health Sciences? (POCI-01-0145-FEDER-007274); and by FCT?grant PTDC/SAU-GMG/098305/2008 to I.S. A.I.S. was the recipient of an FCT scholarship (SFRH/BD/30702/2006). J.R.L. was supported by scholarships from PEst-C/SAU/LA0002/2013 and the European Molecular Biology Organization (ASTF494-2015). C.L.O. was supported by a scholarship from PEst-C/SAU/LA0002/2013. This work was also financed by the Porto Neurosciences and Neurologic Disease Research Initiative at the Instituto de Investiga??o e Inova??o em Sa?de (Norte-01-0145-FEDER-000008), supported by Norte Portugal Regional Operational Programme (NORTE 2020) under the PORTUGAL 2020 Partnership Agreement through FEDER, and by the Fondo de Investigaci?n Sanitaria of the Instituto de Salud Carlos III (grant PI12/00742).
Silveira, I.; Institute for Molecular and Cell Biology, Universidade do Porto, Porto, Portugal;
© Copyright 2017 Elsevier B.V., All rights reserved.